FINAL SAFETY DATA FOR CHINESE PATIENTS (PTS) WITH NON-SQUAMOUS NON-SMALL CELL LUNG CANCER (NSCLC) WHO RECEIVED FIRST-LINE BEVACIZUMAB (BV) PLUS CHEMOTHERAPY IN SAIL (MO10390)
JOURNAL OF THORACIC ONCOLOGY（2010）
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要